• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Bone tissue in patients with hyperprolactinemic hypogonadism].

作者信息

Rozhinskaia L Ia, Marova E I, Dzeranova L K, Rassokhin B M, Purtova G S, Goncharov N P, Mishchenko B P, Ilovaĭskaia I A

出版信息

Probl Endokrinol (Mosk). 1992 Nov-Dec;38(6):17-9.

PMID:1302840
Abstract

Sixteen women with hyperprolactinemia were examined for Ca metabolism, osseous metabolism, mineral saturation of bone tissue in the thoracic portion of the spine and radius. Lowered mineral saturation of the thoracic vertebrae was detected in 69% of the examinees, that of the distal segment of the radius in 44%. Reduction of the mineral saturation of the spine was in negative correlation with the blood prolactin level and length of amenorrhea. No changes in the bone resorption biochemistry or Ca metabolism were detected. A marked reduction of blood osteocalcin level that reflects osteoblast function was detected, its blood concentration being in negative correlation with prolactin level. No relationships between mineral saturation of bone tissue, prolactin, and osteocalcin, on the one hand, and blood estradiol level, on the other, were observed. These data suggest that osteopathy in hyperprolactinemic hypogonadism is due to reduced bone formation and not to reduced estradiol production.

摘要

相似文献

1
[Bone tissue in patients with hyperprolactinemic hypogonadism].
Probl Endokrinol (Mosk). 1992 Nov-Dec;38(6):17-9.
2
The effects of hyperprolactinemia on bone and fat.高催乳素血症对骨骼和脂肪的影响。
Pituitary. 2009;12(2):96-104. doi: 10.1007/s11102-008-0097-3.
3
A longitudinal analysis of premenopausal bone loss in healthy women and women with hyperprolactinemia.健康女性和高泌乳素血症女性绝经前骨质流失的纵向分析。
J Clin Endocrinol Metab. 1992 Sep;75(3):698-703. doi: 10.1210/jcem.75.3.1517357.
4
Effects of prolactin and estrogen deficiency in amenorrheic bone loss.催乳素和雌激素缺乏在闭经性骨质流失中的作用。
J Clin Endocrinol Metab. 1988 Jul;67(1):124-30. doi: 10.1210/jcem-67-1-124.
5
[A study on bone metabolism in woman with hyperprolactinemia].[高催乳素血症女性的骨代谢研究]
Nihon Sanka Fujinka Gakkai Zasshi. 1994 May;46(5):423-8.
6
Plasma calcitonin, IGF-I levels and vertebral bone mineral density in hyperprolactinemic women during bromocriptine treatment.溴隐亭治疗期间高泌乳素血症女性的血浆降钙素、胰岛素样生长因子-I水平及椎骨骨密度
Acta Endocrinol (Copenh). 1993 May;128(5):423-7. doi: 10.1530/acta.0.1280423.
7
The role of cyclase activating (CAP) and cyclase inhibiting (CIP) parathormone fractions in the assessment of bone metabolism disturbances in women with hyperprolactinemia of various origin.环化酶激活(CAP)和环化酶抑制(CIP)甲状旁腺激素组分在评估不同病因高催乳素血症女性骨代谢紊乱中的作用。
Neuro Endocrinol Lett. 2008 Feb;29(1):178-84.
8
Hyperprolactinemia and osteopenia.高催乳素血症与骨质减少。
J Clin Endocrinol Metab. 1992 Sep;75(3):690-1. doi: 10.1210/jcem.75.3.1517355.
9
Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism.精神疾病和精神药物对催乳素及骨代谢的影响。
J Clin Psychiatry. 2004 Dec;65(12):1607-18; quiz 1590, 1760-1. doi: 10.4088/jcp.v65n1205.
10
Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males.高泌乳素血症男性患者对多巴胺激动剂治疗的骨标志物和骨密度反应。
J Clin Endocrinol Metab. 1998 Mar;83(3):807-13. doi: 10.1210/jcem.83.3.4674.